MEDICATION ADMINISTRATION POLICIES:
5.7 CYTOTOXIC DRUGS
|
ANTINEOPLASTICS
|
NON-ANTINEOPLASTICS |
|
|
L-Asparaginase Amsacrine
Bleomycin Bortezomib Busulfan Carboplatin Carmustine Chlorambucil Cisplatin Cladribine Cyclophosphamide Cytarabine
Dacarbazine Dactinomycin Daunorubicin Doxorubicin
Epirubicin Etoposide
Fludarabine Fluorouracil
|
Gemcitabine Hydroxyurea Ifosfamide Lomustine
Mechlorethamine Melphalan Mercaptopurine Methotrexate Mithramycin Mitomycin C Mitotane Mitoxantrone
Procarbazine
Teniposide Thioguanine Thiotepa
Vinblastine Vincristine
|
Azathioprine Gancyclovir Mycophenolate Valganciclovir
|
All medications listed in Table (oral and IV) will be labelled as cytotoxic.
Registered nurses on all units must be knowledgeable about the medication
and safe handling procedures cited in the Patient Care Guideline C-396
Cytotoxic Standards.
Refer to Table G in the Parenteral Drug Therapy Manual (PDTM) for parenteral administration policies relating to cytotoxic drugs.